Back to comparisons

Comparison

Omega-3 (DHA/EPA) vs Fisetin

FieldOmega-3 (DHA/EPA)Fisetin
Categoryneuroprotectiveneuroprotective
Dose range1000–3000mg100–500mg
Half-life24h
Onset
EvidenceEVIDENCEAEVIDENCEB
Safety●●●●●●●●●
Legal (US)USOTCUSOTC
PubMed refs52001700

The comparison in plain English

Auto-generated from data

Omega-3 (DHA/EPA) and Fisetin are both in the neuroprotective category respectively. Omega-3 (DHA/EPA) Essential fatty acids critical for brain structure and function. Fisetin Flavonoid found in strawberries.

Bottom line

Omega-3 (DHA/EPA) (evidence A, safety 5/5) has a weaker evidence base than Fisetin (evidence B, safety 4/5). Omega-3 (DHA/EPA) has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.

Choose Omega-3 (DHA/EPA) if

Omega-3 (DHA/EPA) is the better fit when your goal aligns with its mechanism (DHA (docosahexaenoic acid) is a structural component of neuronal cell membranes, maintaining fluidity and supporting receptor function) and the dose range (1000–3000mg) suits your protocol. Half-life is 24h.

Choose Fisetin if

Fisetin is the better fit when your goal aligns with its mechanism (Senolytic activity — selectively induces apoptosis in senescent cells (cells that have stopped dividing but remain metabolically active and inflammatory)) and the dose range (100–500mg) suits your protocol. Half-life is —h.

Build a stack with bothOpen builder →
Check interactionsOpen checker →